Shkreli Martin

Average Profitability
21.5%
Insider Buys Quantity
39
Insider Buys Sum
$11.02M
Insider Sells Quantity
8
Insider Sells Sum
$29.57M

Insider Activity of Shkreli Martin

The largest purchase of all time was on 2013-12-31 and amounted to 300000 shares of Travere Therapeutics, Inc. for $2.1M.

The largest sale of all time was on 2014-05-30 and amounted to 584800 shares of Travere Therapeutics, Inc. for $8.85M.

Biography of Shkreli Martin

No biography is available at this moment.

2014-11-21SaleTravere Therapeutics, Inc.
TVTX
505,694
1.9005%
$8.41$4.25M+170.75%
2014-11-20SaleTravere Therapeutics, Inc.
TVTX
268,708
0.9319%
$8.23$2.21M+154.52%
2014-11-19SaleTravere Therapeutics, Inc.
TVTX
659,648
2.5644%
$8.54$5.63M+174.97%
2014-11-18SaleTravere Therapeutics, Inc.
TVTX
509,950
1.9112%
$9.19$4.69M+146.35%
2014-11-17SaleTravere Therapeutics, Inc.
TVTX
200,000
0.7334%
$9.41$1.88M+135.4%
2014-11-14SaleTravere Therapeutics, Inc.
TVTX
200,000
0.7608%
$10.23$2.05M+125.35%
2014-10-01SaleTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
600,000
0.0026%
$0.01$6,000+158%
2014-10-01PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
50,000
0.1731%
$8.11$405,330+158%
2014-09-30PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
8,000
0.0308%
$9.42$75,360+146.56%
2014-09-22PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
70,000
0.2663%
$10.82$757,414+107.04%
2014-09-19PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
36,000
0.1408%
$11.78$424,069+93.71%
2014-09-17PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
12,000
0.045%
$11.46$137,480+88.31%
2014-09-16PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
15,000
0.0481%
$10.69$160,380+66.97%
2014-05-30SaleTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
584,800
2.3624%
$15.14$8.85M-14.09%
2014-04-04PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
16,000
0.0644%
$19.64$314,290-35.39%
2014-04-03PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
45,000
0.1879%
$22.60$1.02M-41.73%
2014-04-02PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
21,600
0.0804%
$22.28$481,231-47.32%
2014-03-24PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
8,000
0.0319%
$17.61$140,879-34.89%
2014-03-20PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
10,000
0.0399%
$17.97$179,700-36.18%
2014-03-19PurchaseTravere Therapeutics, Inc.
TVTX
Chief Executive Officer
7,000
0.0307%
$18.44$129,114-31.83%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.